Skip to main content
Erschienen in: Pediatric Nephrology 1/2017

01.12.2015 | Clinical Quiz

A neonate with poor weight gain and hyperkalemia: Answers

verfasst von: Chiung-Chen Liu, Shih-Hua Lin, Chih-Chien Sung, Chien-Ming Lin

Erschienen in: Pediatric Nephrology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Question 1:
An assessment of serum/urine potassium (K) and osmolality values, blood gas analysis results, plasma renin activity (PRA), and serum levels of aldosterone and cortisol are essential.
 
Question 2:
Clinical diagnosis of pseudohypoaldosteronism type 1 (PHA-1) was made on the basis of true volume depletion, hyponatremia, hyperkalemia, hyperreninemic hyperaldosteronism, and normal cortisol level. Molecular genetic analysis of NR3C2 for PHA-1A and the subunit genes (SCNN1A, SCNN1B, SCNN1G) of the amiloride-sensitive epithelial sodium channel (ENaC) for PHA-1B revealed a novel heterozygous mutation in NR3C2, c.2540_2546delAACTATG, in exon 6, resulting in a frameshift p.Glu847Alafs*23 in our patient and her father (Fig. 1).
 
Question 3:
Sodium chloride (NaCl) and bicarbonate (HCO3) supplements and K-binding resins were the mainstay of treatment to normalize the electrolyte imbalance and prevent a life-threatening event.
 
Literatur
1.
Zurück zum Zitat Bowden SA, Cozzi C, Hickey SE, Thrush DL, Astbury C, Nuthakki S (2013) Autosomal dominant pseudohypoaldosteronism type 1 in an infant with salt wasting crisis associated with urinary tract infection and obstructive uropathy. Case Rep Endocrinol 2013:524647PubMedPubMedCentral Bowden SA, Cozzi C, Hickey SE, Thrush DL, Astbury C, Nuthakki S (2013) Autosomal dominant pseudohypoaldosteronism type 1 in an infant with salt wasting crisis associated with urinary tract infection and obstructive uropathy. Case Rep Endocrinol 2013:524647PubMedPubMedCentral
2.
Zurück zum Zitat Amin N, Alvi NS, Barth JH, Field HP, Finlay E, Tyerman K, Frazer S, Savill G, Wright NP, Makaya T, Mushtaq T (2013) Pseudohypoaldosteronism type 1: clinical features and management in infancy. Endocrinol Diabetes Metab Case Rep 2013:130010PubMedPubMedCentral Amin N, Alvi NS, Barth JH, Field HP, Finlay E, Tyerman K, Frazer S, Savill G, Wright NP, Makaya T, Mushtaq T (2013) Pseudohypoaldosteronism type 1: clinical features and management in infancy. Endocrinol Diabetes Metab Case Rep 2013:130010PubMedPubMedCentral
3.
Zurück zum Zitat Bangash AS, Ali NF, Sami S, Iqbal M (2014) Pseudohypoaldosteronism Type-I; a rare cause of hyperkalemia in neonates. J Pak Med Assoc 64:484–486PubMed Bangash AS, Ali NF, Sami S, Iqbal M (2014) Pseudohypoaldosteronism Type-I; a rare cause of hyperkalemia in neonates. J Pak Med Assoc 64:484–486PubMed
4.
Zurück zum Zitat Mora-Lopez F, Bernal-Quiros M, Lechuga-Sancho AM, Lechuga-Campoy JL, Hernandez-Trujillo N, Nieto A (2012) Novel mutation in the epithelial sodium channel causing type I pseudohypoaldosteronism in a patient misdiagnosed with cystic fibrosis. Eur J Pediatr 171:997–1000CrossRefPubMed Mora-Lopez F, Bernal-Quiros M, Lechuga-Sancho AM, Lechuga-Campoy JL, Hernandez-Trujillo N, Nieto A (2012) Novel mutation in the epithelial sodium channel causing type I pseudohypoaldosteronism in a patient misdiagnosed with cystic fibrosis. Eur J Pediatr 171:997–1000CrossRefPubMed
5.
Zurück zum Zitat Ali NF, Zafar F, Bangash AS, Malik A, Mohammedi K (2014) Congenital adrenal hyperplasia with cholestatic jaundice. J Pak Med Assoc 64:110–114PubMed Ali NF, Zafar F, Bangash AS, Malik A, Mohammedi K (2014) Congenital adrenal hyperplasia with cholestatic jaundice. J Pak Med Assoc 64:110–114PubMed
6.
Zurück zum Zitat Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombès M (2007) The mineralocorticoid receptor: insights into its molecular and (patho) physiological biology. Nucl Recept Signal 5:1–16CrossRef Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombès M (2007) The mineralocorticoid receptor: insights into its molecular and (patho) physiological biology. Nucl Recept Signal 5:1–16CrossRef
7.
Zurück zum Zitat Rajpoot SK, Maggi C, Bhangoo A (2014) Pseudohypoaldosteronism in a neonate presenting as life-threatening arrhythmia. Endocrinol Diabetes Metab Case Rep 2014:130077PubMedPubMedCentral Rajpoot SK, Maggi C, Bhangoo A (2014) Pseudohypoaldosteronism in a neonate presenting as life-threatening arrhythmia. Endocrinol Diabetes Metab Case Rep 2014:130077PubMedPubMedCentral
8.
Zurück zum Zitat Welzel M, Akin L, Büscher A, Güran T, Hauffa BP, Högler W, Leonards J, Karges B, Kentrup H, Kirel B, Senses EE, Tekin N, Holterhus PM, Riepe FG (2013) Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1. Eur J Endocrinol 168:707–715CrossRefPubMed Welzel M, Akin L, Büscher A, Güran T, Hauffa BP, Högler W, Leonards J, Karges B, Kentrup H, Kirel B, Senses EE, Tekin N, Holterhus PM, Riepe FG (2013) Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1. Eur J Endocrinol 168:707–715CrossRefPubMed
Metadaten
Titel
A neonate with poor weight gain and hyperkalemia: Answers
verfasst von
Chiung-Chen Liu
Shih-Hua Lin
Chih-Chien Sung
Chien-Ming Lin
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 1/2017
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-015-3281-5

Weitere Artikel der Ausgabe 1/2017

Pediatric Nephrology 1/2017 Zur Ausgabe

Educational Review

C3 Glomerulopathy

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.